ADAPTIMMUNE THERAPEUTICS PLC's ticker is ADAP and the CUSIP is 00653A107. A total of 81 filers reported holding ADAPTIMMUNE THERAPEUTICS PLC in Q3 2020. The put-call ratio across all filers is 0.52 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $1,586,000 | – | 158,400 | – | 0.73% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Syncona Portfolio Ltd | 1,377,294 | $5,165,000 | 4.93% |
| Long Focus Capital Management, LLC | 4,429,491 | $9,125,000 | 1.17% |
| Endurant Capital Management LP | 2,160,890 | $4,451,000 | 1.17% |
| NEA Management Company, LLC | 17,082,611 | $35,190,000 | 1.02% |
| Matrix Capital Management Company, LP | 38,974,185 | $80,287,000 | 0.96% |
| Key Client Fiduciary Advisors, LLC | 420,447 | $866,000 | 0.68% |
| ACT CAPITAL MANAGEMENT, LLC | 90,000 | $185,000 | 0.20% |
| DAFNA Capital Management LLC | 351,064 | $723,000 | 0.19% |
| PFM Health Sciences, LP | 2,374,674 | $4,892,000 | 0.18% |
| Rock Springs Capital Management LP | 2,297,194 | $4,732,000 | 0.12% |